|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$1.2B
|
+$1.68M
|
+18,087
|
+0.1%
|
|
|
2
|
Wellington Management Group
Boston,
Massachusetts
|
$1B
|
+$30.9M
|
+333,358
|
+3%
|
|
|
3
|
Vanguard Group
Malvern,
Pennsylvania
|
$475M
|
+$38.6M
|
+416,709
|
+9%
|
|
|
4
|
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$257M
|
+$187M
|
+2,018,484
|
+285%
|
|
|
5
|
Capital World Investors
Los Angeles,
California
|
$183M
|
-$464K
|
-5,000
|
-0.3%
|
|
|
6
|
|
$181M
|
+$903K
|
+9,741
|
+0.5%
|
|
|
7
|
BlackRock Institutional Trust
San Francisco,
California
|
$167M
|
+$1.05M
|
+11,275
|
+0.6%
|
|
|
8
|
BlackRock Fund Advisors
San Francisco,
California
|
$162M
|
-$16.5M
|
-177,587
|
-9%
|
|
|
9
|
State Street
Boston,
Massachusetts
|
$158M
|
+$11.7M
|
+126,382
|
+8%
|
|
|
10
|
Jennison Associates
New York
|
$140M
|
+$676K
|
+7,296
|
+0.5%
|
|
|
11
|
Gilder Gagnon Howe & Co
New York
|
$139M
|
-$1.53M
|
-16,480
|
-1%
|
|
|
12
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$117M
|
-$7.64M
|
-82,350
|
-6%
|
|
|
13
|
First Trust Advisors
Wheaton,
Illinois
|
$115M
|
-$31.4M
|
-338,836
|
-22%
|
|
|
14
|
BB Biotech
Schaffhausen,
Switzerland
|
$107M
|
–
|
–
|
–
|
|
|
15
|
|
$103M
|
-$10.7M
|
-115,371
|
-10%
|
|
|
16
|
Blue Ridge Capital
New York
|
$101M
|
–
|
–
|
–
|
|
|
17
|
Franklin Resources
San Mateo,
California
|
$91.1M
|
+$2.71M
|
+29,200
|
+3%
|
|
|
18
|
Wells Fargo
San Francisco,
California
|
$72.9M
|
-$245K
|
-2,640
|
-0.3%
|
|
|
19
|
Slate Path Capital
New York
|
$68.3M
|
+$12.1M
|
+130,000
|
+22%
|
|
|
20
|
Bridger Management
New York
|
$67.5M
|
+$476K
|
+5,132
|
+0.7%
|
|
|
21
|
12 West Capital Management
New York
|
$61.3M
|
–
|
–
|
–
|
|
|
22
|
|
$56.3M
|
-$6.19M
|
-66,811
|
-10%
|
|
|
23
|
|
$54M
|
+$3.68M
|
+39,701
|
+7%
|
|
|
24
|
Alpha Wave Global
New York
|
$46.3M
|
–
|
–
|
–
|
|
|
25
|
|
$44.7M
|
+$3.71M
|
+40,000
|
+9%
|
|
